Eventually, the NAMD team wants to take 20% or so of the machine for their work, but for now, they are working out what few driver and compiler issues they have hit along the way. The team expects ...

To evaluate the neovascular age-related macular degeneration (nAMD) in patients who were morphologically poor responders to intravitreal ranibizumab (IVR) treatment using indocyanine green ...

The FDA has approved updates to Susvimo, which will be available to US retina specialists and patients with nAMD in the coming weeksSusvimo offers the first alternative to regular eye injections ...

Switching from other anti-vascular endothelial growth factor (VEGF) therapies to faricimab in patients with neovascular age-related macular degeneration (nAMD) was found to induce short-term ...

P041, an aflibercept biosimilar, showed noninferiority to originator aflibercept (Eylea) in maintaining vision in nAMD patients over 52 weeks. The study involved 168 patients, with 145 completing ...

Cataract Surgery and nAMD: A Deeper Dive Into Outcomes and Treatment Effects —Cataract surgery significantly improves both distance and near vision in patients with neovascular age-related ...

Community Case in nAMD This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. 0.50 CME. 30 MINS. $0 FEE. SAVE. Add topic to email alerts ...

BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere to treatment than those ...